| Mary Beth Crist, APRN | |
|
1101 N Main St, Mcpherson, KS 67460-2845 | |
| (620) 241-4477 | |
| (620) 241-2716 |
| Full Name | Mary Beth Crist |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist |
| Location | 1101 N Main St, Mcpherson, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265771182 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364S00000X | Clinical Nurse Specialist | 53-74963-061 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Beth Crist, APRN 1101 N Main St, Mcpherson, KS 67460-2845 Ph: (620) 241-4477 | Mary Beth Crist, APRN 1101 N Main St, Mcpherson, KS 67460-2845 Ph: (620) 241-4477 |
News Archive
Ho Jeong and his colleague from Korea presented a case of duodenal obstruction after successful selective transcatheter arterial embolization (TAE) for a duodenal diverticular hemorrhage. Their study will be published on August 14, 2009 in the World Journal of Gastroenterology.
Teva Pharmaceutical Industries Ltd. announced today that a jury returned a verdict in the U.S. District Court for the District of New Jersey finding that Nycomed's U.S. Patent No. 4,758,579 is not invalid. The Court has reserved decision on the issue of what, if any, effect to give to the jury's determinations in connection with the obviousness-type double patenting defenses, which Teva has argued is to be decided by the Court.
Use of gemcitabine, a drug that can be effective in treating advanced and resected pancreatic cancer, did not result in improved overall survival after pancreatic cancer resection (surgical removal) compared to patients who received fluorouracil and folinic acid, another treatment regimen that has shown effectiveness, according to a study in the September 8 issue of JAMA.
In a new study published in Disease Models & Mechanisms, scientists use the zebrafish to gain insight into the influence of known cancer genes on the development and progression of melanoma, an aggressive form of human skin cancer with limited treatment options.
Writing in Huffington Post's "The Big Push" blog, Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, notes "countries from north and south, U.N. organizations, private sector companies and non-governmental organizations (NGOs) are meeting in Geneva [this week] at the Board meeting of the Global Fund to Fight AIDS, Tuberculosis and Malaria to discuss how best to invest available resources against the three killer diseases."
› Verified 7 days ago